Literature DB >> 22071773

The application of statistical methods using VOCs to identify patients with lung cancer.

Agnieszka Ulanowska1, Tomasz Kowalkowski, Ewa Trawińska, Bogusław Buszewski.   

Abstract

In this work, an attempt was made to determine a group of lung cancer biomarkers. For this study, breath samples collected from 137 patients with confirmed lung cancer were analyzed by the SPME-GC/MS method. As a reference group, exhaled air from 143 healthy volunteers with different smoking habits (active smokers, passive smokers and nonsmokers) was applied. Statistical methods such as discriminant analysis (DA) and the CHAID model tree were used for data processing and evaluation. In the breath of patients with lung cancer, increased concentration of ethanol, acetone, butane, dimethyl sulfide, isoprene, propanal, 1-propanol, 2-pentanone, furan, o-xylene and ethylbenzene was observed in comparison to healthy nonsmokers. Furthermore, pentanal, hexanal and nonane were identified only in the breath of people who suffered from cancer. DA confirmed the importance of these compounds and allowed us to identify patients with lung cancer from healthy volunteers. In the exhaled air of healthy smokers (passive and active), a higher concentration of acetonitrile, benzene and furan derivatives was observed than in nonsmokers. DA revealed that in order to recognize healthy volunteers with different smoking habits by breath analysis, butyrolactone, carbon disulfide and dimethyl sulfide have to be considered.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22071773     DOI: 10.1088/1752-7155/5/4/046008

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  24 in total

1.  Distinguish oral-source VOCs and control their potential impact on breath biomarkers.

Authors:  Dianlong Ge; Jijuan Zhou; Yajing Chu; Yan Lu; Xue Zou; Lei Xia; Yawei Liu; Chaoqun Huang; Chengyin Shen; Liwei Zhang; Huanzhong Wang; Yannan Chu
Journal:  Anal Bioanal Chem       Date:  2022-01-04       Impact factor: 4.142

2.  Accuracy and Methodologic Challenges of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis.

Authors:  George B Hanna; Piers R Boshier; Sheraz R Markar; Andrea Romano
Journal:  JAMA Oncol       Date:  2019-01-10       Impact factor: 31.777

3.  Comparison of Targeted and Untargeted Approaches in Breath Analysis for the Discrimination of Lung Cancer from Benign Pulmonary Diseases and Healthy Persons.

Authors:  Michalis Koureas; Dimitrios Kalompatsios; Grigoris D Amoutzias; Christos Hadjichristodoulou; Konstantinos Gourgoulianis; Andreas Tsakalof
Journal:  Molecules       Date:  2021-04-29       Impact factor: 4.411

4.  Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer.

Authors:  Andras Bikov; Marton Hernadi; Beata Zita Korosi; Laszlo Kunos; Gabriella Zsamboki; Zoltan Sutto; Adam Domonkos Tarnoki; David Laszlo Tarnoki; Gyorgy Losonczy; Ildiko Horvath
Journal:  BMC Pulm Med       Date:  2014-12-16       Impact factor: 3.317

5.  Exhaled volatile organic compounds analysis in clinical pediatrics: a systematic review.

Authors:  Rosa A Sola Martínez; José M Pastor Hernández; Óscar Yanes Torrado; Manuel Cánovas Díaz; Teresa de Diego Puente; María Vinaixa Crevillent
Journal:  Pediatr Res       Date:  2020-09-12       Impact factor: 3.756

6.  Differential Response of Pentanal and Hexanal Exhalation to Supplemental Oxygen and Mechanical Ventilation in Rats.

Authors:  Lukas M Müller-Wirtz; Daniel Kiefer; Joschua Knauf; Maximilian A Floss; Jonas Doneit; Beate Wolf; Felix Maurer; Daniel I Sessler; Thomas Volk; Sascha Kreuer; Tobias Fink
Journal:  Molecules       Date:  2021-05-07       Impact factor: 4.411

7.  Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography-mass spectrometry.

Authors:  Wadah Ibrahim; Rebecca L Cordell; Michael J Wilde; Matthew Richardson; Liesl Carr; Ananga Sundari Devi Dasi; Beverley Hargadon; Robert C Free; Paul S Monks; Christopher E Brightling; Neil J Greening; Salman Siddiqui
Journal:  ERJ Open Res       Date:  2021-07-05

8.  Lung cancer biomarkers: State of the art.

Authors:  Sangeetha Subramaniam; Ram Krishna Thakur; Vinod Kumar Yadav; Ranjan Nanda; Shantanu Chowdhury; Anurag Agrawal
Journal:  J Carcinog       Date:  2013-02-28

Review 9.  Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review.

Authors:  Kim D G van de Kant; Linda J T M van der Sande; Quirijn Jöbsis; Onno C P van Schayck; Edward Dompeling
Journal:  Respir Res       Date:  2012-12-21

10.  Investigation of VOCs associated with different characteristics of breast cancer cells.

Authors:  Luca Lavra; Alexandro Catini; Alessandra Ulivieri; Rosamaria Capuano; Leila Baghernajad Salehi; Salvatore Sciacchitano; Armando Bartolazzi; Sara Nardis; Roberto Paolesse; Eugenio Martinelli; Corrado Di Natale
Journal:  Sci Rep       Date:  2015-08-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.